These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19627602)

  • 1. Haptoglobin inhibits phospholipid transfer protein activity in hyperlipidemic human plasma.
    Henderson RJ; Wasan KM; Leon CG
    Lipids Health Dis; 2009 Jul; 8():27. PubMed ID: 19627602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in human phospholipid transfer protein activity following incubation of Fungizone compared to lipid-based Amphotericin-B formulations in normolipidemic and hyperlipidemic plasma.
    Henderson RJ; Leon CG; Wasan KM
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1139-46. PubMed ID: 19381990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remodeling of apolipoprotein E-containing spherical reconstituted high density lipoproteins by phospholipid transfer protein.
    Settasatian N; Barter PJ; Rye KA
    J Lipid Res; 2008 Jan; 49(1):115-26. PubMed ID: 17921435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass concentration of plasma phospholipid transfer protein in normolipidemic, type IIa hyperlipidemic, type IIb hyperlipidemic, and non-insulin-dependent diabetic subjects as measured by a specific ELISA.
    Desrumaux C; Athias A; Bessède G; Vergès B; Farnier M; Perségol L; Gambert P; Lagrost L
    Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):266-75. PubMed ID: 9974406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of plasma phospholipid transfer protein increases the risk of atherosclerosis despite lower apolipoprotein B-containing lipoproteins.
    Lie J; de Crom R; van Gent T; van Haperen R; Scheek L; Sadeghi-Niaraki F; van Tol A
    J Lipid Res; 2004 May; 45(5):805-11. PubMed ID: 14993244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active plasma phospholipid transfer protein is associated with apoA-I- but not apoE-containing lipoproteins.
    Cheung MC; Albers JJ
    J Lipid Res; 2006 Jun; 47(6):1315-21. PubMed ID: 16520487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma apolipoprotein E concentration is an important determinant of phospholipid transfer protein activity in type 2 diabetes mellitus.
    Tan KC; Shiu SW; Wong Y; Wong WK; Tam S
    Diabetes Metab Res Rev; 2006; 22(4):307-12. PubMed ID: 16389649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoproteins A1 and B levels and serum cholinesterase activity in hyperlipidemic subjects.
    Olinic D; Stoia M; Marian I; Trif I; Cucuianu M
    Rom J Intern Med; 1999; 37(1):71-9. PubMed ID: 15523947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human plasma phospholipid transfer protein specific activity is correlated with HDL size: implications for lipoprotein physiology.
    Cheung MC; Wolfbauer G; Deguchi H; Fernández JA; Griffin JH; Albers JJ
    Biochim Biophys Acta; 2009 Mar; 1791(3):206-11. PubMed ID: 19162221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma phospholipid transfer protein activity in patients with low HDL and cardiovascular disease treated with simvastatin and niacin.
    Cheung MC; Wolfbauer G; Kennedy H; Brown BG; Albers JJ
    Biochim Biophys Acta; 2001 Sep; 1537(2):117-24. PubMed ID: 11566255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between plasma phospholipid transfer protein activity and HDL subclasses among patients with low HDL and cardiovascular disease.
    Cheung MC; Wolfbauer G; Brown BG; Albers JJ
    Atherosclerosis; 1999 Jan; 142(1):201-5. PubMed ID: 9920522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of plasma phospholipid transfer protein activity with IDL and buoyant LDL: impact of gender and adiposity.
    Cheung MC; Knopp RH; Retzlaff B; Kennedy H; Wolfbauer G; Albers JJ
    Biochim Biophys Acta; 2002 May; 1587(1):53-9. PubMed ID: 12009424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression.
    Valenta DT; Ogier N; Bradshaw G; Black AS; Bonnet DJ; Lagrost L; Curtiss LK; Desrumaux CM
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1572-8. PubMed ID: 16675720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the electrostatic charge of lipoprotein particles on the activity of the human plasma phospholipid transfer protein.
    Desrumaux C; Athias A; Masson D; Gambert P; Lallemant C; Lagrost L
    J Lipid Res; 1998 Jan; 39(1):131-42. PubMed ID: 9469592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular cholesterol efflux to plasma from proteinuric patients is elevated and remains unaffected by antiproteinuric treatment.
    Vogt L; Laverman GD; van Tol A; Groen AK; Navis G; Dullaart RP
    Nephrol Dial Transplant; 2006 Jan; 21(1):101-6. PubMed ID: 16141462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol.
    Dullaart RP; Groen AK; Dallinga-Thie GM; de Vries R; Sluiter WJ; van Tol A
    Eur J Endocrinol; 2008 Jan; 158(1):53-60. PubMed ID: 18166817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of phospholipid transfer protein in lipoprotein-mediated neutralization of the procoagulant effect of anionic liposomes.
    Oslakovic C; Jauhiainen M; Ehnholm C; Dahlbäck B
    J Thromb Haemost; 2010 Apr; 8(4):766-72. PubMed ID: 20088939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of plasma lipid transfer proteins in reverse cholesterol transport.
    Yamashita S; Sakai N; Hirano K; Ishigami M; Maruyama T; Nakajima N; Matsuzawa Y
    Front Biosci; 2001 Mar; 6():D366-87. PubMed ID: 11229884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage PLTP is atheroprotective in LDLr-deficient mice with systemic PLTP deficiency.
    Valenta DT; Bulgrien JJ; Bonnet DJ; Curtiss LK
    J Lipid Res; 2008 Jan; 49(1):24-32. PubMed ID: 17928634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased phospholipid transfer protein activity associated with the impaired cellular cholesterol efflux in type 2 diabetic subjects with coronary artery disease.
    Attia N; Nakbi A; Smaoui M; Chaaba R; Moulin P; Hammami S; Hamda KB; Chanussot F; Hammami M
    Tohoku J Exp Med; 2007 Oct; 213(2):129-37. PubMed ID: 17917406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.